Ellington Management Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3,100
| Closed | -$268K | – | 279 |
|
|
2020
Q1 | $268K | Buy |
+3,100
| New | +$268K | 0.06% | 345 |
|
|
2017
Q3 | – | Sell |
-17,100
| Closed | -$787K | – | 770 |
|
|
2017
Q2 | $787K | Buy |
17,100
+5,500
| +47% | +$253K | 0.11% | 125 |
|
|
2017
Q1 | $502K | Buy |
+11,600
| New | +$502K | 0.02% | 294 |
|
|
2015
Q4 | – | Sell |
-5,300
| Closed | -$211K | – | 731 |
|
|
2015
Q3 | $211K | Buy |
+5,300
| New | +$211K | 0.06% | 559 |
|